Loss of the putative tumor suppressor band 4.1B/Dal1 gene is dispensable for normal development and does not predispose to cancer

Molecular and Cellular Biology

Volumn 25, Issue 22, 2005, Pages 10052-10059

  Yi, Chunling ^a   McCarty, Joseph H ^b,d   Troutman, Scott A ^a   Eckman, Matthew S ^b   Bronson, Roderick T ^c   Kissil, Joseph L ^a  

^a WISTAR INSTITUTE   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSKELETON PROTEIN; ERYTHROCYTE BAND 4.1 PROTEIN; EZRIN; MERLIN; MOESIN; RADIXIN;

ADENOCARCINOMA; ALLELE; ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER SUSCEPTIBILITY; CELL PROLIFERATION; CHROMOSOME MAP; FIBROBLAST; GENE FUNCTION; GENETIC CONSERVATION; LUNG ADENOCARCINOMA; MENINGIOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN LOCALIZATION; TUMOR SUPPRESSOR GENE;

ALLELES; ANIMALS; APOPTOSIS; BLOTTING, SOUTHERN; BLOTTING, WESTERN; BRAIN; CELL DEATH; CELL PROLIFERATION; CELLS, CULTURED; CLONING, MOLECULAR; CYTOSKELETAL PROTEINS; DNA PRIMERS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; IMMUNOHISTOCHEMISTRY; KINETICS; LUNG; MAMMARY GLANDS, ANIMAL; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MODELS, GENETIC; MUTATION; NEOPLASMS; POLYMERASE CHAIN REACTION;

ANIMALIA;

EID: 27644457349     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.25.22.10052-10059.2005     Document Type: Article

References (29)

1. Chishti, A. H., A. C. Kim, S. M. Marfatia, M. Lutchman, M. Hanspal, H. Jindal, S. C. Liu, P. S. Low, G. A. Rouleau, N. Mohandas, J. A. Chasis, J. G. Conboy, P. Gascard, Y. Takakuwa, S. C. Huang, E. J. Benz, Jr., A. Bretscher, R. G. Fehon, J. F. Gusella, V. Ramesh, F. Solomon, V. T. Marchesi, S. Tsukita, K. B. Hoover, et al. 1998. The FERM domain: a unique module involved in the linkage of cytoplasmic proteins to the membrane. Trends Biochem. Sci. 23:281-282.
2. Denisenko-Nehrbass, N., K. Oguievetskaia, L. Goutebroze, T. Galvez, H. Yamakawa, O. Ohara, M. Carnaud, and J. A. Girault. 2003. Protein 4.1B associates with both Caspr/paranodin and Caspr2 at paranodes and juxtaparanodes of myelinated fibres. Eur. J. Neurosci. 17:411-416.
3. Gimm, J. A., X. An, W. Nunomura, and N. Mohandas. 2002. Functional characterization of spectrin-actin-binding domains in 4.1 family of proteins. Biochemistry 41:7275-7282.
4. Gutmann, D. H., J. Donahoe, A. Perry, N. Lemke, K. Gorse, K. Kittiniyom, S. A. Rempel, J. A. Gutierrez, and I. F. Newsham. 2000. Loss of DAL-1, a protein 4.1-related tumor suppressor, is an important early event in the pathogenesis of meningiomas. Hum. Mol. Genet. 9:1495-1500.
5. Gutmann, D. H., C. A. Haipek, S. P. Burke, C. X. Sun, D. R. Scoles, and S. M. Pulst. 2001. The NE2 interactor, hepatocyte growth factor-regulated tyrosine kinase substrate (HRS), associates with merlin in the "open" conformation and suppresses cell growth and motility. Hum. Mol. Genet. 10: 825-834.
6. Gutmann, D. H., A. C. Hirbe, Z. Y. Huang, and C. A. Haipek. 2001. The protein 4.1 tumor suppressor, DAL-1, impairs cell motility, but regulates proliferation in a cell-type-specific fashion. Neurobiol. Dis. 8:266-278.
7. Heinrich, B., C. Hartmann, A. O. Stemmer-Rachamimov, D. N. Louis, and M. MacCollin. 2003. Multiple meningiomas: Investigating the molecular basis of sporadic and familial forms. Int. J. Cancer 103:483-488.
8. Hori, T., E. Takabashi, D. Ayusawa, K. Takeishi, S. Kaneda, and T. Seno. 1990. Regional assignment of the human thymidylate synthase (TS) gene to chromosome band 18p11.32 by nonisotopic in situ hybridization. Hum. Genet. 85:576-580.
9. Jackson, E. L., N. Willis, K. Mercer, R. T. Bronson, D. Crowley, R. Montoya, T. Jacks, and D. A. Tuveson. 2001. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev. 15:3243-3248.
10. Johnson, C. V., D. E. Cool, M. B. Glaccum, N. Green, E. H. Fischer, A. Bruskin, D. E. Hill, and J. B. Lawrence. 1993. Isolation and mapping of human T-cell protein tyrosine phosphatase sequences: localization of genes and pseudogenes discriminated using fluorescence hybridization with genomic versus cDNA probes. Genomics 16:619-629.
11. Kawakami, K., Y. Ishida, K. D. Danenberg, K. Omura, G. Watanabe, and P. V. Danenberg. 2002. Functional polymorphism of the thymidylate synthase gene in colorectal cancer accompanied by frequent loss of heterozygosity. Jpn. J. Cancer Res. 93:1221-1229.
12. Kittiniyom, K., M. Mastronardi, M. Roemer, W. A. Wells, E. R. Greenberg, L. Titus-Ernstoff, and I. F. Newsham. 2004. Allele-specific loss of heterozygosity at the DAL-1/4.1B (EPB41L3) tumor-suppressor gene locus in the absence of mutation. Genes Chromosomes Cancer 40:190-203.
13. Kuns, R., J. L. Kissil, I. F. Newsham, T. Jacks, D. H. Gutmann, and L. S. Sherman. 20 June 2005. Protein 4.1B expression is induced in mammary epithelial cells during pregnancy and regulates their proliferation. Oncogene 10.1038/sj.onc.1208813.
14. Parra, M., P. Gascard, L. D. Walensky, J. A. Gimm, S. Blackshaw, N. Chan, Y. Takakuwa, T. Berger, G. Lee, J. A. Chasis, S. H. Snyder, N. Mohandas, and J. G. Conboy. 2000. Molecular and functional characterization of protein 4.1B, a novel member of the protein 4.1 family with high level, focal expression in brain. J. Biol. Chem. 275:3247-3255.
15. Perry, A., D. X. Cai, B. W. Scheithauer, P. E. Swanson, C. M. Lohse, I. F. Newsham, A. Weaver, and D. H. Gutmann. 2000. Merlin, DAL-1, and progesterone receptor expression in clinicopathologic subsets of meningioma: a correlative immunohistochemical study of 175 cases. J. Neuropathol. Exp. Neurol. 59:872-879.
16. Peters, L. L., H. U. Weier, L. D. Walensky, S. H. Snyder, M. Parra, N. Mohandas, and J. G. Conboy. 1998. Four paralogous protein 4.1 genes map to distinct chromosomes in mouse and human. Genomics 54: 348-350.
17. Robb, V. A., W. Li, P. Gascard, A. Perry, N. Mohandas, and D. H. Gutmann. 2003. Identification of a third protein 4.1 tumor suppressor, protein 4.1R, in meningioma pathogenesis. Neurobiol. Dis. 13:191-202.
18. Sage, J., G. J. Mulligan, L. D. Attardi, A. Miller, S. Chen, B. Williams, E. Theodorou, and T. Jacks. 2000. Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization. Genes Dev. 14: 3037-3050.
19. Scholzen, T., and J. Gerdes. 2000. The Ki-67 protein: from the known and the unknown. J. Cell Physiol. 182:311-322.
20. Shi, Z. T., V. Afzal, B. Coller, D. Patel, J. A. Chasis, M. Parra, G. Lee, C. Paszty, M. Stevens, L. Walensky, L. L. Peters, N. Mohandas, E. Rubin, and J. G. Conboy. 1999. Protein 4.1R-deficient mice are viable but have erythroid membrane skeleton abnormalities. J. Clin. Investig. 103:331-340.
21. Sun, C. X., V. A. Robb, and D. H. Gutmann. 2002. Protein 4.1 tumor suppressors: getting a FERM grip on growth regulation. J. Cell Sci. 115: 3991-4000.
22. Tchernia, G., N. Mohandas, and S. B. Shohet. 1981. Deficiency of skeletal membrane protein band 4.1 in homozygous hereditary elliptocytosis. Implications for erythrocyte membrane stability. J. Clin. Investig. 68:454-460.
23. Tran, Y., K. Benbatoul, K. Gorse, S. Rempel, A. Futreal, M. Green, and I. Newsham. 1998. Novel regions of allelic deletion on chromosome 18p in tumors of the lung, brain and breast. Oncogene 17:3499-3505.
24. Tran, Y. K., O. Bogler, K. M. Gorse, I. Wieland, M. R. Green, and I. F. Newsham. 1999. A novel member of the NF2/ERM/4.1 superfamily with growth suppressing properties in lung cancer. Cancer Res. 59:35-43.
25. Uchida, K., K. Hayashi, K. Kawakami, S. Schneider, J. M. Yochim, H. Kuramochi, K. Takasaki, K. D. Danenberg, and P. V. Danenberg. 2004. Loss of heterozygosity at the thymidylate synthase (TS) locus on chromosome 18 affects tumor response and survival in individuals heterozygous for a 28-bp polymorphism in the TS gene. Clin. Cancer Res. 10: 433-439.
26. Yamakawa, H., and O. Ohara. 2000. Comparison of mRNA and protein levels of four members of the protein 4.1 family: the type II brain 4.1/4.1B/KIAA0987 is the most predominant member of the protein 4.1 family in rat brain. Gene 248:137-145.
27. Ye, K., D. A. Compton, M. M. Lai, L. D. Walensky, and S. H. Snyder. 1999. Protein 4.1N binding to nuclear mitotic apparatus protein in PC12 cells mediates the antiproliferative actions of nerve growth factor. J. Neurosci. 19:10747-10756.
28. Ye, K., K. J. Hurt, F. Y. Wu, M. Fang, H. R. Luo, J. J. Hong, S. Blackshaw, C. D. Ferris, and S. H. Snyder. 2000. Pike. A nuclear gtpase that enhances PI3kinase activity and is regulated by protein 4.1N. Cell 103:919-930.
29. Yu, T., V. A. Robb, V. Singh, D. H. Gutmann, and I. F. Newsham. 2002. The 4.1/ezrin/radixin/moesin domain of the DAL-1/protein 4.1B tumour suppressor interacts with 14-3-3 proteins. Biochem. J. 365:783-789.